Hologic is a global champion of women’s health. We integrate The Science of Sure into everything we do to help improve and save lives through early detection and proactive treatment.


Nam tincidunt felis ac arcu ultrices, a mattis lectus imperdiet. Sed suscipit suscipit consectetur. Nulla velit ante, molestie sit amet massa fringilla, rutrum venenatis purus. Fusce tempus tempus velit, quis malesuada quam accumsan non. Donec ornare, eros tincidunt aliquet iaculis, purus quam porta felis, non suscipit turpis nunc et elit. Donec sagittis dolor et nisi venenatis varius. Quisque accumsan eros mauris, condimentum tempor est ullamcorper non. Pellentesque interdum, odio eleifend hendrerit pellentesque, magna eros sagittis tellus, vitae pretium orci metus nec urna.


3Dimensions® Mammography System
A better 3D™ breast screening experience...
Acessa® Laparoscopic Radiofrequency Ablation (Lap-RFA)
The Acessa procedure is a minimally...
Aptima Combo 2® assay (for CT/NG)
STIs are on the rise. Chlamydia...
Aptima HPV +ThinPrep Cervical Health
Leading the charge in cervical disease...
Brand Categories

Panther Fusion® Open Access™

Laboratory Developed Tests (LDTs) are an essential part of diagnostics. Patients with certain medical conditions depend on these in-house developed tests when other options are not available. Save time and increase efficiency by consolidating your LDTs and IVD assays on the fully automated, sample-to-result, Panther Fusion system using the Open Access™ functionality.

Aptima® Vaginal Health

The Aptima vaginitis panel from Hologic consists of molecular nucleic acid amplification tests (NAAT) to aid in the detection of vaginosis and vaginitis. Our assays detect the three most common causes of infectious vaginitis: bacterial vaginosis, candida vaginitis and trichomoniasis.

Aptima® HIV-1 Quant Dx Assay

Dual-claim assay to confirm HIV-1 infection and measure viral load.

Aptima® Herpes Simplex 1 & 2 assay

Globally, over 4.1 billion people are infected with HSV-1 and HSV-2 and the signs and symptoms can overlap.1 It is only through laboratory tests that these subtypes can be differentiated, which is important for managing herpes infections and identifying the risk of transmission to neonates and among sex partners.2,3

Aptima® HCV Quant Dx Assay

Confirmation of active HCV infection and monitoring HCV viral load on the fully automated Panther® system.  

Aptima® HBV Quant Assay

Deliver trusted results with dual targets across a wide linear range and all major HBV genotypes.

Aptima® CMV Quant Assay

FDA-Approved solution to reliably and efficiently deliver actionable viral load insights to post-transplant patients and their care teams.  

Panther® Scalable Solutions

Panther Scalable Solutions allows you to expand your testing menu while adding on flexibility, capacity and walkaway time.

Panther Fusion® Respiratory Assays

The Panther Fusion Respiratory assays are the premier set of assays on the Panther Fusion system. You can provide truly personalized syndromic respiratory testing with qualitative detection and differentiation of the most common respiratory viruses from a single patient sample. Each Panther Fusion Respiratory assay can be processed independently or simultaneously with other Panther Fusion and Aptima® assays.
The Panther Fusion Flu A/B/RSV, Panther Fusion Paraflu and Panther Fusion AdV/hMPV/RV assays comprise the IVD respiratory testing menu on the fully automated Panther Fusion system. Each is a multiplex, real-time PCR in vitro diagnostic test. These assays can be run on nasopharyngeal (NP) swab specimens obtained from individuals exhibiting signs and symptoms of a respiratory tract infection.1-3  Additionally, the Panther Fusion SARS-CoV-2 assay has received Emergency Use Authorization for the detection of SARS-CoV-2 from nasopharyngeal, nasal, mid-turbinate and oropharyngeal swab specimens, nasopharyngeal wash/aspirate or nasal wash, and lower respiratory tract specimens.4

Hologic Transplant Assay

Give patients a better chance at life with our Transplant Portfolio of quantitative tests for the quantification of post-transplant infections.  

CMV and Viral Load Monitoring

Cytomegalovirus (CMV) infection is a common complication that affects organ transplant patients. CMV, a member of the herpes virus family, establishes a lifelong latent infection that is generally asymptomatic. However, in immunocompromised patients, such as transplant recipients, reactivation of latent CMV is often life-threatening. Guidelines recommend regular monitoring of CMV viral load as an aid for diagnosis of CMV infections and monitoring response to treatment.1, 2